Request Trial
shutterstock_1524542537_michael_vi
Michael Vi / Shutterstock.com
4 May 2021MedTechAlex Baldwin

Conformis launches implant lawsuit against J&J subsidiary

US medtech company Conformis has filed a lawsuit against J&J Medical Devices-owned DePuy Synthes, alleging that it infringed on its custom implant and surgery software patents.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

MedTech
Boston Scientific overturns $42m patent verdict on appeal
28 July 2026   Years of litigation over biodegradable drug-delivery technology took another turn after the Federal Circuit delivered a significant win for the medical device maker.
MedTech
AbbVie, Allergan takes on Swiss aesthetics rival over syringe design
23 July 2026   The latest clash between two facial aesthetics rivals centres on a Swiss rival’s newly approved syringe, which AbbVie and Allergan claim infringes five US design patents.
MedTech
UPC upholds injunction in Invisalign maker’s software dispute with rival
9 July 2026   China-headquartered Angelalign failed to convince UPC appellate judges to overturn a ban that affects its ability to offer orthodontic planning software in Europe with certain functionality.


Editor's picks

Buying the brains: Why is Big Pharma shopping for innovation?
Regulation & Industry
Buying the brains: Why is Big Pharma shopping for innovation?
27 July 2026

Editor's picks

Regulation & Industry
Buying the brains: Why is Big Pharma shopping for innovation?
27 July 2026

More features

Fish & Richardson adds AI and medical device specialist
Where Big Pharma is betting big in the M&A boom
Boston Scientific overturns $42m patent verdict on appeal
Buying the brains: Why is Big Pharma shopping for innovation?
FisherBroyles and Hong Kong affiliate draft in senior partners
‘Engagement and collaboration’: New IP Federation president builds on strong foundations
AbbVie, Allergan takes on Swiss aesthetics rival over syringe design
Trump slaps 100% tariff on generic drugs in US manufacturing push